Hansruedi Glatt

How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.

Raffaella Corvi, Elizabeth Parry, Lutz Müller, 2007, Mutation research.

STRUCTURAL ELUCIDATION OF HYDROXYLATED METABOLITES OF THE ISOFLAVAN EQUOL BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY

Sabine E. Kulling, H. Glatt, S. Kulling, 2006, Drug Metabolism and Disposition.

Strategy for genotoxicity testing--metabolic considerations.

R Scott Obach, Masamitsu Honma, Warren W Ku, 2007, Mutation research.

Genetically Engineered Cell Lines: Characterisation and Applications in Toxicity Testing

Walter Luyten, Daniel A. Casciano, Maurice Dickins, 1997 .

Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters.

Abraham Brouwer, Dick Tibboel, Walter Meinl, 2002, The Journal of clinical endocrinology and metabolism.

In Silico Prediction of Human Sulfotransferase 1E1 Activity Guided by Pharmacophores from Molecular Dynamics Simulations*

Gerhard Wolber, Christin Rakers, Burkhard Kleuser, 2015, The Journal of Biological Chemistry.

Identification and localization of soluble sulfotransferases in the human gastrointestinal tract.

Simone Florian, Walter Meinl, H. Glatt, 2007, The Biochemical journal.

Polymorphisms in sulfotransferases SULT1A1 and SULT1A2 are not related to colorectal cancer

Heiner Boeing, Victor Moreno, Walter Meinl, 2005, International journal of cancer.

Constitutive expression of bioactivating enzymes in normal human prostate suggests a capability to activate pro‐carcinogens to DNA‐damaging metabolites

Eva Frei, Walter Meinl, H. Glatt, 2010, The Prostate.